Drug Database
Back to search

Netherlands· NL-828beb1581ff

Artesunate Amivas 110 mg poeder en oplosmiddel voor oplossing voor injectie

A artesunate product containing artesunaat, registered in Netherlands by Amivas Ireland Limited. The same ATC class is registered in 12 of our 19 countries.

ATC P01BE03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedArtesunate Amivas 110 mg poeder en op…ATCP01BE03REGISTER NO.NL-828beb1581ffPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about artesunaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Artesunate is registered in 12 of 19 countries.

Countries holding a registration under ATC P01BE03 (artesunate), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search artesunate products by name

Artesunate · ATC P01BE03

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ARTESUNAAT
Manufacturer
Amivas Ireland Limited
Country
Netherlands (NL)
ATC code
P01BE03
ATC class
Artesunate
Defined daily dose
0.28 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/21/1582

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

106 interactions on record for artesunate.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check artesunate against other medicinesHow interaction checks work

Artesunate · interactions on record

106 records

  • 2 severe
  • 104 moderate

Most severe, free to view

  • EluxadolineA07DA06severe
  • GrazoprevirJ05AP11severe
  • RolapitantA04AD14moderate
  • EliglustatA16AX10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Artesunate in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All artesunate products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Artesunate Amivas
  • Liechtenstein · Artesunate Amivas
  • Norway · Artesunate Amivas

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/86bc59f5-67cf-4537-ab49-56368bfbf9fe
GET /v1/drugs/86bc59f5-67cf-4537-ab49-56368bfbf9fe?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder en oplosmiddel voor oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/artesunate-amivas-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Artesunate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp127364",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
    "FOSFORZUUR (E 338)",
    "NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
    "NATRIUMHYDROXIDE (E 524)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "ARTESUNAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2021/11/23",
  "procedure_number": "EMEA/H/C/005550",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/21/1582",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about artesunate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console